Description

BSE announces listing of Commercial Paper worth Rs. 100 crore issued by SBICAP Securities Limited on private placement basis with redemption date of March 6, 2026.

Summary

BSE has listed new Commercial Paper issued by SBICAP Securities Limited on private placement basis. The instrument consists of 2,000 securities of Rs. 5,00,000 each (total Rs. 100 crore) with credit ratings of CRISIL A1+ and ICRA A1+. The securities were allotted on December 5, 2025 and will mature on March 6, 2026. State Bank of India acts as the Issuing and Paying agent.

Key Points

  • Securities: Commercial Paper issued on private placement basis
  • Face Value: Rs. 5,00,000 per unit
  • Issue Price: Rs. 4,91,954 per unit
  • Total Quantity: 2,000 units (Rs. 100 crore)
  • Scrip Code: 730717
  • Scrip ID: SBI051225
  • ISIN: INE212K14CV7
  • Credit Rating: CRISIL A1+, ICRA A1+
  • Market Lot: 1 unit
  • Tick Size: 1 paise
  • Trading: Only in dematerialized form
  • Standard Denomination: Rs. 5 Lakhs and multiples thereof
  • Issuing and Paying Agent: State Bank of India

Regulatory Changes

No regulatory changes announced in this circular.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE212K14CV7
  • Trading shall take place in standard denomination of Rs. 5 Lakhs and multiples thereof
  • The tick size for the securities is 1 paise
  • Trading members requiring clarification may contact the debt department at 22728352/8597/8995/5753/8915

Important Dates

  • Listing Date: December 8, 2025
  • Allotment Date: December 5, 2025
  • Redemption Date: March 6, 2026

Impact Assessment

This is a routine debt instrument listing with minimal market impact. The commercial paper provides short-term funding for SBICAP Securities Limited over a 91-day period. The high credit ratings (A1+ from both CRISIL and ICRA) indicate strong creditworthiness. Impact is limited to debt market participants interested in highly-rated short-term corporate debt instruments. No impact on equity markets or broader market operations.

Impact Justification

Routine commercial paper listing announcement with no regulatory changes or market-wide impact, affecting only specific debt instrument trading.